Advertisement
News
Advertisement

Acetylon starts multiple myeloma treatment trial

Fri, 09/23/2011 - 8:33am
Mass High Tech: The Journal of New England Technology

Multiple myeloma, an incurable blood cancer, is the target of two separate clinical trials launched this week to study and treat the disease. While Wednesday saw the enrollment of the first person in a 1,000-patient study focused on personalized medicine strategies, today Acetylon Pharmaceuticals Inc. of Boston has begun a Phase 1-2a clinical trial of its multiple myeloma treatment, ACY-1215.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading